01 March 2006
Effect of mercuric chloride on urinary excretion of free hydroxyproline.
Nikhat Jamal Siddiqi, Abdullah Salih AlhomidaMed Sci Monit 2006; 12(3): BR95-101 :: ID: 447102
Abstract
Background: The present study was undertaken to study the effect of mercuricchloride (HgCl[sub]2[/sub]) on the collagen metabolism in rats and the protective effect of 2, 3-dimercapto-1-propanesulfonic acid (DMPS) in HgCl[sub]2[/sub]-treated rats. Material/Methods: The experimental groups studied were(i) a control group (ii) rats injected with a single intraperitoneal (ip) dose of 2 mg of HgCl[sub]2[/sub]/kgbody weight (HgCl[sub]2[/sub]-treated group, n=10 rats), (iii) Rats injected with a single dose (ip) of 100 mgof DMPS/kg body weight (DMPS group, n=10 rats), (iv) rats injected with a single dose (ip) of 100 mgof DMPS/kg body weight followed by a single dose (ip) of 2 mg of HgCl[sub]2[/sub]/kg body weight 1 hour aftera 100-mg DMPS injection (DMPS + HgCl[sub]2[/sub]-treated group, n=10 rats). Half of the rats from each group weresacrificed after 24 hours and the other half after 48 hours of treatment. Results: A dose of 2.0 mg HgCl[sub]2[/sub]/kgbody weight caused an impairment of glomerular function, which was reflected by significant increasesin the levels of serum creatinine and serum urea nitrogen in HgCl[sub]2[/sub]-treated rats compared with controlrats. Administration of 2.0 mg of HgCl[sub]2[/sub]/kg body weight significantly increased urinary excretion offree hydroxyproline in HgCI[sub]2[/sub]-treated rats compared with the control rats, reflecting increased collagenbreakdown. Conclusions: Administration of DMPS one hour before HgCl[sub]2[/sub] treatment caused the restorationof altered parameters to near normal levels.
Keywords: Blood Urea Nitrogen, Body Weight - drug effects, Collagen - metabolism, Creatinine - blood, Dose-Response Relationship, Drug, Hydroxyproline - urine, Injections, Intraperitoneal, Kidney Diseases - prevention & control, Kidney Glomerulus - drug effects, Mercuric Chloride - pharmacology, Organ Size - drug effects, Rats, Wistar, Unithiol - pharmacology
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952